These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3162109)

  • 1. The gait abnormality of Huntington's disease.
    Koller WC; Trimble J
    Neurology; 1985 Oct; 35(10):1450-4. PubMed ID: 3162109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Dujardin K; Destée A; Derambure P; Defebvre L
    J Neurol; 2006 Jan; 253(1):73-80. PubMed ID: 16096818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
    Piolti R; Appollonio I; Perego M; Pozzi C; Rovati L; Ferrarese C; Frattola L
    Eur Neurol; 1995; 35(6):344-8. PubMed ID: 8591802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum haloperidol concentration and choreiform movements in Huntington's disease.
    Barr AN; Fischer JH; Koller WC; Spunt AL; Singhal A
    Neurology; 1988 Jan; 38(1):84-8. PubMed ID: 2962009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind trial of lithium carbonate and haloperidol in Huntington's chorea.
    Leonard DP; Kidson MA; Brown JG; Shannon PJ; Taryan S
    Aust N Z J Psychiatry; 1975 Jun; 9(2):115-8. PubMed ID: 125578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait in Huntington's disease and the stride length-cadence relationship.
    Danoudis M; Iansek R
    BMC Neurol; 2014 Oct; 14():161. PubMed ID: 25265896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Velocity modulation and rhythmic synchronization of gait in Huntington's disease.
    Thaut MH; Miltner R; Lange HW; Hurt CP; Hoemberg V
    Mov Disord; 1999 Sep; 14(5):808-19. PubMed ID: 10495043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of amantadine and haloperidol in Huntington's chorea.
    Saran BM; Klein MS; Benay EM
    J Clin Psychiatry; 1980 Jun; 41(6):221. PubMed ID: 6445900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Haloperidol, reserpine, l-dopa and amantidine in the treatment of Huntington chorea (author's transl)].
    Candelise L
    Riv Patol Nerv Ment; 1976; 96(1):54-62. PubMed ID: 134449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoregressive modeling to assess stride time pattern stability in individuals with Huntington's disease.
    Alzakerin HM; Halkiadakis Y; Morgan KD
    BMC Neurol; 2019 Dec; 19(1):316. PubMed ID: 31818276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falls and gait disturbances in Huntington's disease.
    Grimbergen YAM; Knol MJ; Bloem BR; Kremer BPH; Roos RAC; Munneke M
    Mov Disord; 2008 May; 23(7):970-976. PubMed ID: 18381643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium carbonate in Huntington's chorea.
    Manyam NV; Bravo-Fernandez E
    Lancet; 1973 May; 1(7810):1010. PubMed ID: 4121579
    [No Abstract]   [Full Text] [Related]  

  • 16. 2-dimethylaminoethanol (Deanol) in Huntington's chorea.
    Caraceni TA; Girotti F; Celano I; Parati E; Balboni L
    J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1114-8. PubMed ID: 153384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.
    Consolo S; Ladinsky H; Bianchi S; Caraceni T
    Arch Psychiatr Nervenkr (1970); 1977 May; 223(3):265-70. PubMed ID: 142461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural control and gait measures derived from wearable inertial measurement unit devices in Huntington's disease: Recommendations for clinical outcomes.
    Desai R; Blacutt M; Youdan G; Fritz NE; Muratori LM; Hausdorff JM; Busse M; Quinn L
    Clin Biomech (Bristol, Avon); 2022 Jun; 96():105658. PubMed ID: 35588586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Double-blind trial of lithium carbonate and haloperidol in Huntington's chorea.
    Leonard DP; Kidson MA; Shannon PJ; Brown J
    Lancet; 1974 Nov; 2(7890):1208-9. PubMed ID: 4139622
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
    Kegelmeyer DA; Kloos AD; Fritz NE; Fiumedora MM; White SE; Kostyk SK
    J Neurol Sci; 2014 Dec; 347(1-2):219-23. PubMed ID: 25456459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.